Amniotic Membrane Market Size (2024 - 2029)

Amniotic Membrane Market Analysis

The Amniotic Membrane Market size is estimated at USD 2.99 billion in 2024, and is expected to reach USD 4.26 billion by 2029, growing at a CAGR of 12.10% during the forecast period (2024-2029).

• Factors such as a rise in accident and trauma cases, increasing awareness about the benefits of an amniotic membrane, and rising research on stem cell biology and regenerative medicines are the major driving factors for market growth. Additionally, the growing number of surgeries performed and rising expenditure on research and development (R&D) in stem cells and regenerative medicine are key factors driving the overall market.
• For instance, as per the data published by the United States Department of Labor in December 2022, over 5,190 fatal work injuries were reported in the United States in 2022, which increased from 4,764 cases compared to the previous year. Burn injuries represent a significant disease burden on the world population, with nearly 9 million injuries and an estimated 120,000-180,000 deaths annually, as mentioned in the research paper published in October 2022. According to the above-mentioned research, almost 18 million disability-adjusted life years (DALYs) can be accounted for burns, with a disproportionate 90% of this burden borne by LMICs.
• Also, in Bangladesh, Colombia, Egypt, and Pakistan, burn injuries account for up to 18% of permanent disabilities, as per the same research above. The amniotic membrane is commonly used to treat up to second-degree burn wounds. Thus, the rising burden of burn injuries globally is expected to create a high demand for the amniotic membrane for the purpose of tissue repair and regeneration, and it is expected to boost market growth during the forecast period.
• The market consists of several major players, and their strategic product innovation is garnering market growth. For instance, in February 2022, Amnio Technology, a global leader in the development of and distribution of amniotic tissue allografts, launched two new palingen membrane products, palingen dual-layer membrane and dual-layer palingen x-membrane. Like the entire family of PalinGen membrane products, the new allografts are minimally manipulated, homologous, and chorion-free. The palinGen membrane and dual-layer palinGen X-membrane are indicated for patients suffering from non-healing acute and chronic wounds and complex or open surgical wounds and burns. Thus, continuous innovation in the amniotic membrane market is expected to drive the market's overall growth.
• In January 2022, Laboratoires Thea SAS, a prominent independent pharmaceutical company in Europe, finalized the acquisition of seven branded ophthalmic products from Akorn Operating Company LLC. This includes AcellFX, which is an acellular amniotic membrane that offers a protective covering for repairing the ocular surface.
• Therefore, owing to the factors above, it is anticipated that the market will witness growth during the forecast period. However, the lack of standardized guidelines and skilled professionals will likely impede market growth.

Amniotic Membrane Industry Segmentation

The amniotic membrane consists of a combination of tissues and cells, and it is the innermost layer of the placenta, which is widely used in ophthalmology and wound healing.

The amniotic membrane market is segmented by enzyme, application, end user, and geography. By enzymes, the market is segmented as cryopreserved amniotic membrane and dehydrated amniotic membrane. By application, the market is segmented as ophthalmology, surgical wounds, and other applications. By end user, the market is segmented as hospitals, ambulatory surgical centers, and other end users. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally.

The report offers the value (USD) for the above segments.